Lexicon Pharmaceuticals (LXRX) Insider Trading & Ownership

$1.69

+0.06 (+3.68%)

(As of 10/10/2024 ET)

Current Insider Ownership Percentage: 6.80%
Number Of Insiders Buying (Last 12 Months): 2
Amount Of Insider Buying (Last 12 Months): $837,353.44
Number Of Insiders Selling (Last 12 Months): 0

Get LXRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexicon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LXRX Insider Buying and Selling by Quarter

Ad Weiss Ratings

Protect Your Bank Account with THESE 4 Simple Steps

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Lexicon Pharmaceuticals Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
11/16/2023	Lonnel Coats	CEO	Buy	90,000	$1.05	$94,500.00
11/10/2023	Lonnel Coats	CEO	Buy	10,000	$1.01	$10,100.00
10/12/2023	Raymond Debbane	Director	Buy	148,820	$1.03	$153,284.60
10/10/2023	Raymond Debbane	Director	Buy	508,306	$1.14	$579,468.84

(Data available from 1/1/2013 forward)

LXRX Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Lexicon Pharmaceuticals includes International S.C.A. Artal, Jeffrey L Wade, Lonnel Coats, Raymond Debbane, and Wendy Mcdermott. Learn more on insiders at LXRX.
: 6.80% of Lexicon Pharmaceuticals stock is owned by insiders. Learn more on LXRX's insider holdings.
: The following insiders have purchased LXRX shares in the last 24 months: International S.C.A. Artal ($72,215,130.00), Jeffrey L Wade ($41,760.00), Lonnel Coats ($240,400.00), Raymond Debbane ($732,753.44), and Wendy Mcdermott ($35,340.00).
: Insiders have purchased a total of 28,630,176 LXRX shares in the last 24 months for a total of $73,265,383.44 bought.

Lexicon Pharmaceuticals Key Executives

Mr. Jeffrey L. Wade J.D. (Age 59)
President & COO
Compensation: $752.05k
Mr. Brian T. Crum (Age 51)
Senior VP, General Counsel & Secretary
Compensation: $596.48k
Dr. Alan J. Main Ph.D. (Age 70)
Executive Vice President of Innovation & Chemical Sciences
Compensation: $576.96k
Dr. Craig B. Granowitz M.D. (Age 59)
Ph.D., Senior VP & Chief Medical Officer
Compensation: $652.48k
Dr. Michael Exton Ph.D. (Age 54)
CEO & Director
Ms. Kristen L. Alexander (Age 56)
Vice President of Finance & Accounting
Ms. Lisa M. DeFrancesco (Age 45)
Vice President of Investor Relations, Corporate Strategy & Communications
Mr. Dixon Terry
Vice President of Compliance
Ms. Carrie Siragusa
Vice President of Marketing
Ms. Desiree Gendron
Vice President of Sales & Training